載入中
NASDAQHealthcareMedical - Distribution
最新資料
US$0.107
−US$0.005 · -4.46%
Cellyan Biotechnology Co., Ltd, an investment holding entity, primarily operates within the over-the-counter (OTC) pharmaceutical sector, serving markets across Hong Kong and mainland China. The company's services encompass the international sourcing and distribution of OTC medications, alongside comprehensive e-commerce supply chain management. Furthermore, it provides essential logistical support, including customs clearance, drug registration, and warehousing facilities. Cellyan Biotechnology caters to a diverse clientele, which includes logistics partners for e-commerce platforms, various merchants, and pharmaceutical distributors. Founded in 2023, the company is based in Yau Tong, Hong Kong. It was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and officially adopted the name Cellyan Biotechnology Co., Ltd in December 2025.
一般交易時段
US$0.107
−US$0.005 · -4.46%
盤中時間採用ET。市場資料可能有所延遲。
Cellyan Biotechnology Co., Ltd, an investment holding entity, primarily operates within the over-the-counter (OTC) pharmaceutical sector, serving markets across Hong Kong and mainland China. The company's services encompass the international sourcing and distribution of OTC medications, alongside comprehensive e-commerce supply chain management. Furthermore, it provides essential logistical support, including customs clearance, drug registration, and warehousing facilities. Cellyan Biotechnology caters to a diverse clientele, which includes logistics partners for e-commerce platforms, various merchants, and pharmaceutical distributors. Founded in 2023, the company is based in Yau Tong, Hong Kong. It was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and officially adopted the name Cellyan Biotechnology Co., Ltd in December 2025.
日內區間
目前US$0.107
52週區間
目前US$0.107
盤中時間採用ET。市場資料可能有所延遲。
Cellyan Biotechnology Co., Ltd, an investment holding entity, primarily operates within the over-the-counter (OTC) pharmaceutical sector, serving markets across Hong Kong and mainland China. The company's services encompass the international sourcing and distribution of OTC medications, alongside comprehensive e-commerce supply chain management. Furthermore, it provides essential logistical support, including customs clearance, drug registration, and warehousing facilities. Cellyan Biotechnology caters to a diverse clientele, which includes logistics partners for e-commerce platforms, various merchants, and pharmaceutical distributors. Founded in 2023, the company is based in Yau Tong, Hong Kong. It was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and officially adopted the name Cellyan Biotechnology Co., Ltd in December 2025.
日內區間
目前US$0.107
52週區間
目前US$0.107
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2026會計年度 | 2025會計年度 | 2024會計年度 | 2023會計年度 |
|---|---|---|---|---|
| 營收 | 1343.35萬 USD | 2031.38萬 USD | 1668.84萬 USD | 1255.6萬 USD |
| 銷貨成本 | 1204.72萬 USD | 1789.87萬 USD | 1312.97萬 USD | 981.71萬 USD |
| 毛利 | 138.63萬 USD | 241.52萬 USD | 355.87萬 USD | 273.89萬 USD |
| 銷售、一般及管理費用 | 239.51萬 USD | 221.59萬 USD | 188.95萬 USD | 175.81萬 USD |
| 營業費用 | 238.12萬 USD | 228.31萬 USD | 195.04萬 USD | 169.51萬 USD |
| 利息收入 | — | 1741 USD | 474 USD | 219 USD |
| 利息支出 | 13.34萬 USD | 9.77萬 USD | 8.28萬 USD | 2.32萬 USD |
| 折舊和攤銷 | 68.71萬 USD | 107.34萬 USD | 92.56萬 USD | 71.46萬 USD |
| 營業利益 | −99.49萬 USD | 13.2萬 USD | 160.83萬 USD | 104.38萬 USD |
| 淨利 | −113.6萬 USD | −2.71萬 USD | 132.97萬 USD | 99.82萬 USD |
公司資料更新於 2026年10月12日。
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
